Funding for the mhGAP Programme, under which the work reported in this manuscript was done, was provided by the following: American Psychiatric Foundation, USA; Association of Aichi Psychiatric Hospitals, Japan; Autism Speaks, USA; CBM; Government of Italy; Government of Japan; Government of The Netherlands; International Bureau for Epilepsy; International League Against Epilepsy; Medical Research Council, UK; National Institute of Mental Health, USA; Public Health Agency of Canada, Canada; Rockefeller Foundation, USA; Shirley Foundation, UK; Syngenta, Switzerland; United Nations Population Fund;World Psychiatric Associatio
This is an updated protocol to the 2013 Cochrane review: Non-specialist health worker interventions...
Mental, neurological, and substance use disorders are common in all regions of the world, affecting ...
PURPOSE OF REVIEW: The aim was to synthesize recent evidence on schizophrenia illness experience and...
Question: Despite mental, neurological and substance use (MNS) disorders being highly prevalent, the...
QUESTION: Despite mental, neurological and substance use (MNS) disorders being highly prevalent, th...
Abstract In 2011, the World Health Organization's (WHO) mental health Gap Action Programme (mhGAP) r...
Serious Mental Illnesses (SMI) are psychiatric disorders(excluding developmental and substance use d...
Background: In addition to services within the health system, interventions at the population and co...
Contains fulltext : 56006.pdf (publisher's version ) (Closed access)We review the ...
AIMS: In recent years a number of intergovernmental initiatives have been activated in order to enh...
Abstract There is a large treatment gap for mental health care in low- and middle-inco...
PURPOSE OF REVIEW: The aim was to synthesize recent evidence on schizophrenia illness experience and...
Mental, neurological, and substance use disorders (MNS) are among the largest sources of medical dis...
Mental and neurological disorders (MNDs) account for a large, and growing, burden of disease in low-...
There is a large treatment gap for mental health care in low- and middle-income countries (LMICs), w...
This is an updated protocol to the 2013 Cochrane review: Non-specialist health worker interventions...
Mental, neurological, and substance use disorders are common in all regions of the world, affecting ...
PURPOSE OF REVIEW: The aim was to synthesize recent evidence on schizophrenia illness experience and...
Question: Despite mental, neurological and substance use (MNS) disorders being highly prevalent, the...
QUESTION: Despite mental, neurological and substance use (MNS) disorders being highly prevalent, th...
Abstract In 2011, the World Health Organization's (WHO) mental health Gap Action Programme (mhGAP) r...
Serious Mental Illnesses (SMI) are psychiatric disorders(excluding developmental and substance use d...
Background: In addition to services within the health system, interventions at the population and co...
Contains fulltext : 56006.pdf (publisher's version ) (Closed access)We review the ...
AIMS: In recent years a number of intergovernmental initiatives have been activated in order to enh...
Abstract There is a large treatment gap for mental health care in low- and middle-inco...
PURPOSE OF REVIEW: The aim was to synthesize recent evidence on schizophrenia illness experience and...
Mental, neurological, and substance use disorders (MNS) are among the largest sources of medical dis...
Mental and neurological disorders (MNDs) account for a large, and growing, burden of disease in low-...
There is a large treatment gap for mental health care in low- and middle-income countries (LMICs), w...
This is an updated protocol to the 2013 Cochrane review: Non-specialist health worker interventions...
Mental, neurological, and substance use disorders are common in all regions of the world, affecting ...
PURPOSE OF REVIEW: The aim was to synthesize recent evidence on schizophrenia illness experience and...